Eric Venker, Chief Executive Officer at Immunovant, Inc. (IMVT), sold 3,506 shares at $34.11 ($120K) on 2026-10-02, disclosed to the SEC on 2026-10-05.
Open-market sale of $120k IMVT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ROIV | SELL | 2026-07-29 | $7.0M | — | Filing → |
| IMVT | SELL | 2026-07-06 | $119K | — | Filing → |
| ROIV | SELL | 2026-06-26 | $6.6M | — | Filing → |